Study Finds Racial Disparity in Which Patients Receive Advanced Pulmonary Embolism Treatment
People of color suffering a pulmonary embolism were more likely to die in hospitals than their white counterparts.
People of color suffering a pulmonary embolism were more likely to die in hospitals than their white counterparts.
Researchers said neither the side effects of Xeljanz, or similar drugs appear to increase the risk of venous thromboembolism-related injuries.
Pfizer allegedly knew about the blood clot risks with Xeljanz, but misled patients and the medical community in order to maximize profits.